盟科药业股价跌5.01%，民生加银基金旗下1只基金重仓，持有2.26万股浮亏损失8588元

Group 1 - The core point of the news is that Mengke Pharmaceutical's stock price dropped by 5.01% to 7.21 CNY per share, with a trading volume of 1.04 billion CNY and a turnover rate of 2.70%, resulting in a total market capitalization of 47.27 billion CNY [1] - Mengke Pharmaceutical, established on August 7, 2012, and listed on August 5, 2022, is located in the China (Shanghai) Free Trade Pilot Zone and focuses on innovative drugs for infectious diseases, holding global intellectual property rights and international competitiveness [1] - The company's main revenue source is from Kantizole tablets, which accounts for 100% of its business income [1] Group 2 - From the perspective of fund holdings, Minsheng Jianyin Fund has a significant position in Mengke Pharmaceutical, with the Minsheng Jianyin Pension Service Mixed Fund (002547) holding 22,600 shares, representing 1.05% of the fund's net value, making it the sixth-largest holding [2] - The Minsheng Jianyin Pension Service Mixed Fund has a total scale of 19.6553 million CNY and has experienced a loss of 3.7% this year, ranking 8099 out of 8150 in its category [2] - The fund has also incurred a loss of 2.3% over the past year, ranking 7930 out of 8043, while achieving a cumulative return of 55.24% since its inception [2]